CAPEMART

Capecitabine Tablets LP 500 mg (commonly known as Xeloda) are an oral chemotherapy medication used in the treatment of various cancers, particularly Breast Cancer, Colorectal Cancer, and Gastric Cancer. Capecitabine is a prodrug that is converted inside the body into 5-fluorouracil (5-FU), an active anti-cancer agent that interferes with DNA synthesis and slows or stops the growth of cancer cells. The “LP” (low permeability/modified release) formulation is designed to improve tolerability and maintain effective drug levels over time.

Taken orally, usually in divided doses after meals, it offers a convenient alternative to intravenous chemotherapy while delivering comparable efficacy in many treatment regimens. It is often used alone or in combination with other anti-cancer drugs depending on the stage and type of cancer. Common side effects may include diarrhea, nausea, fatigue, hand-foot syndrome (redness and swelling of palms and soles), and loss of appetite, while serious risks include low blood cell counts, infections, and liver function abnormalities, requiring regular monitoring during therapy. Capecitabine LP 500 mg provides an effective, patient-friendly chemotherapy option that supports long-term cancer management under strict medical supervision.